Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Breast 2Thoracic 1

Conditions

Neutropenia 5Breast Neoplasms 5Febrile Neutropenia 3Wilms Tumor 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Malignant Solid Tumors 1Lymphoma 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breastcancer 1Breast Cancer Female 1

Interventions

pegylated granulocyte colony-stimulating factor 3pegfilgrastim 3Vancomycin 3Interleukin 1 Receptor Antagonist Protein 2Filgrastim 2Ceftazidime 2Cefepime 2Amikacin 2Vaccination 1Teicoplanin 1Tazobactam 1Surveys and Questionnaires 1Sodium Chloride 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Piperacillin 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Meropenem 1Linezolid 1Itraconazole 1Injections 1Cloxacillin 1Ciprofloxacin 1Cilastatin, Imipenem Drug Combination 1Bevacizumab 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Febrile Neutropenia × pegylated granulocyte colony-stimulating factor × Clear all
NCT04466137 2022-02-09

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Xiamen Amoytop Biotech Co., Ltd.

Phase 3 Completed
398 enrolled
Classical hematology

Neutropenia, Febrile Neutropenia

NCT02005458 2018-07-17

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Xiamen Amoytop Biotech Co., Ltd.

Phase 2 Completed
80 enrolled
BreastClassical hematologyThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neutropenia, Febrile Neutropenia

NCT02119715 2014-04-22

A Phase II Study Comparing Pegylated rhG-CSF(HHPG-19K) and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
182 enrolled
BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡